Sterile Injectables & Fill-Finish
CSL Seqirus - Holly Springs
Holly Springs, North Carolina
About CSL Seqirus - Holly Springs
CSL Seqirus operates a vaccine manufacturing facility in Holly Springs, North Carolina. The Holly Springs plant was established to produce Flucelvax, a cell-based seasonal influenza vaccine, and to provide formulation and fill-finish services for prefilled syringes. It handles formulation and fill-finish of prefilled syringes, supporting the end-to-end manufacturing of Flucelvax. CSL Seqirus also provides antivenoms and a Q fever vaccine, with the Holly Springs site contributing to the company's broad influenza portfolio. The company cites its three-continent manufacturing footprint and integrated supply chain as key to timely global vaccine delivery.
Manufacturing capabilities
Finishing & coating
Industries served
Public health · Government health agencies · Global vaccine distribution
Company details
- Location
- Holly Springs, North Carolina
- Company type
- Manufacturer
Frequently asked questions
Where is CSL Seqirus - Holly Springs located?
CSL Seqirus - Holly Springs is located at Holly Springs, North Carolina.
What does CSL Seqirus - Holly Springs do?
CSL Seqirus - Holly Springs is listed under Sterile Injectables & Fill-Finish, and its listed capabilities and products include Vaccine Manufacturing, Cell-Based Influenza Vaccine Production, Formulation, Fill-Finish and Prefilled Syringe Fill-Finish.
What industries does CSL Seqirus - Holly Springs serve?
CSL Seqirus - Holly Springs lists Public health, Government health agencies and Global vaccine distribution among the industries it serves.
How do I request a quote from CSL Seqirus - Holly Springs?
Use the Request a quote button on this page to send CSL Seqirus - Holly Springs your requirements through FirmsLedger, or visit csl.com.
What companies are similar to CSL Seqirus - Holly Springs?
Other Sterile Injectables & Fill-Finish companies in North Carolina listed on FirmsLedger include Pfizer - Rocky Mount, Novo Nordisk - Clayton and Eli Lilly and Company - Research Triangle Park.